In lung cancer, a higher expression of the PAK4 gene, as indicated by microarray analysis, predicted shorter OS of non-small cell lung cancers, but the immunohistochemical expression of PAK4 did not predict the OS of patients [9]. This evidence concerns the gene PAK4 and lung carcinoma.